作者: Eng-King Tan
DOI: 10.1038/NRNEUROL.2013.212
关键词:
摘要: New research indicates that next-generation sequencing (NGS) can improve the diagnostic yield in a highly selected group of patients with ataxia, following comprehensive exclusion work-up other causes. However, routine practical application NGS will depend on refinement current technologies to facilitate data interpretation, and cost-effectiveness analysis different patient groups.